Primary experimental recordPositive observation

PMC10135057::ACT000359

F-NZ2114

Evidence text

Paper-level observation

Section 2.8.1: None of the concentrations of FNZ produced hemolytic activity on erythrocytes; no damage to mouse red blood cells (MRBCs) with FNZ in all scope-effective concentrations.

textConfidence: medium

Assay observation

Activity

Toxicity

Subtype

Hemolytic

Measure

hemolysis

Comparator

Raw observation

Normalized measurement

=0%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

mouse red blood cells (MRBCs)

Assay method

Not reported by source

Sequence

Not reported by source

Standardization

insufficient information

Source publication

Molecular Modification of Kex2 P1' Site Enhances Expression and Druggability of Fungal Defensin

Antibiotics · 2023

DOI 10.3390/antibiotics12040786 PMC10135057

Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.